These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21175659)

  • 41. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing.
    Alvarez do Barrio M; González Díez R; Hernández Sánchez JM; Oyonarte Gómez S
    Euro Surveill; 2005 Feb; 10(2):20-2. PubMed ID: 15735311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands.
    Borkent-Raven BA; Janssen MP; van der Poel CL; de Wit GA; Bonsel GJ; van Hout BA
    Transfusion; 2009 Feb; 49(2):311-9. PubMed ID: 19389213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
    Mafirakureva N; Mapako T; Khoza S; Emmanuel JC; Marowa L; Mvere D; Postma MJ; van Hulst M
    Transfusion; 2016 Dec; 56(12):3101-3111. PubMed ID: 27696441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
    Fasola FA; Kotila TR; Akinyemi JO
    Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cost-benefit analysis of blood donor vaccination as an alternative to additional DNA testing for reducing transfusion transmission of hepatitis B virus.
    Fischinger JM; Stephan B; Wasserscheid K; Eichler H; Gärtner BC
    Vaccine; 2010 Nov; 28(49):7797-802. PubMed ID: 20875488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Status of NAT screening for HCV, HIV and HBV: experience in Japan.
    Tomono T; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Murozuka T; Emura H; Doi Y; Mine H; Yokoyama S; Ohnuma H; Tanaka T; Yoshikawa A; Nishioka K;
    Dev Biol (Basel); 2002; 108():29-39. PubMed ID: 12220140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing.
    Murokawa H; Yoshikawa A; Ohnuma H; Iwata A; Katoh N; Miyamoto M; Mine H; Emura H; Tadokoro K;
    Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B virus blood screening: impact of nucleic amplification technology testing implementation on identifying hepatitis B surface antigen non-reactive window period and chronic infections.
    Iudicone P; Miceli M; Palange M; Agresti A; Gallo A; Isacchi G; Girolami E; Pierelli L; Mannella E
    Vox Sang; 2009 May; 96(4):292-7. PubMed ID: 20701733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003.
    Niederhauser C; Schneider P; Fopp M; Ruefer A; Lévy G
    Euro Surveill; 2005 Feb; 10(2):14-6. PubMed ID: 15735314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Romanian blood donors screening: is it really necessary and/or mandatory?
    Hâţu G; Brumboiu MI; Gorgan IN; Bocşan IS
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):741-6. PubMed ID: 24502043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003).
    Velati C; Fomiatti L; Baruffi L; Romanò L; Zanetti A;
    Euro Surveill; 2005 Feb; 10(2):12-4. PubMed ID: 15735315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk for transfusion-transmitted infectious diseases in Central and South America.
    Schmunis GA; Zicker F; Pinheiro F; Brandling-Bennett D
    Emerg Infect Dis; 1998; 4(1):5-11. PubMed ID: 9452393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices.
    Theodoropoulos N; Jaramillo A; Ladner DP; Ison MG
    Am J Transplant; 2013 Aug; 13(8):2186-90. PubMed ID: 23711196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT).
    Pillonel J; Laperche S;
    Euro Surveill; 2005 Feb; 10(2):5-8. PubMed ID: 15735313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India.
    Shyamala V
    Transfus Med; 2014 Apr; 24(2):79-88. PubMed ID: 24605952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.